187 related articles for article (PubMed ID: 30761222)
1. Treatment of Multiple Myeloma in Elderly Patients: A Review of Literature and Practice Guidelines.
Manapuram S; Hashmi H
Cureus; 2018 Dec; 10(12):e3669. PubMed ID: 30761222
[TBL] [Abstract][Full Text] [Related]
2. Novel Induction Regimens in Multiple Myeloma.
Runcie KD; Mark TM
Curr Hematol Malig Rep; 2015 Dec; 10(4):388-94. PubMed ID: 26275667
[TBL] [Abstract][Full Text] [Related]
3. Management of Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma.
Laubach J; Kumar S
Cancer Treat Res; 2016; 169():145-167. PubMed ID: 27696262
[TBL] [Abstract][Full Text] [Related]
4. [The guidelines for the diagnosis and management of multiple myeloma in China(2020 revision)].
; ;
Zhonghua Nei Ke Za Zhi; 2020 May; 59(5):341-346. PubMed ID: 32370461
[TBL] [Abstract][Full Text] [Related]
5. Management of Newly Diagnosed Elderly Multiple Myeloma Patients.
Antoine-Pepeljugoski C; Braunstein MJ
Curr Oncol Rep; 2019 May; 21(7):64. PubMed ID: 31127403
[TBL] [Abstract][Full Text] [Related]
6. Treatment for patients with newly diagnosed multiple myeloma in 2015.
Mateos MV; Ocio EM; Paiva B; Rosiñol L; Martínez-López J; Bladé J; Lahuerta JJ; García-Sanz R; San Miguel JF
Blood Rev; 2015 Nov; 29(6):387-403. PubMed ID: 26094881
[TBL] [Abstract][Full Text] [Related]
7. Real-life data on safety and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma.
Marini C; Maia T; Bergantim R; Pires J; Aguiar E; Guimarães JE; Trigo F
Ann Hematol; 2019 Feb; 98(2):369-379. PubMed ID: 30368589
[TBL] [Abstract][Full Text] [Related]
8. Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study.
Moreau P; Attal M; Hulin C; Arnulf B; Belhadj K; Benboubker L; Béné MC; Broijl A; Caillon H; Caillot D; Corre J; Delforge M; Dejoie T; Doyen C; Facon T; Sonntag C; Fontan J; Garderet L; Jie KS; Karlin L; Kuhnowski F; Lambert J; Leleu X; Lenain P; Macro M; Mathiot C; Orsini-Piocelle F; Perrot A; Stoppa AM; van de Donk NW; Wuilleme S; Zweegman S; Kolb B; Touzeau C; Roussel M; Tiab M; Marolleau JP; Meuleman N; Vekemans MC; Westerman M; Klein SK; Levin MD; Fermand JP; Escoffre-Barbe M; Eveillard JR; Garidi R; Ahmadi T; Zhuang S; Chiu C; Pei L; de Boer C; Smith E; Deraedt W; Kampfenkel T; Schecter J; Vermeulen J; Avet-Loiseau H; Sonneveld P
Lancet; 2019 Jul; 394(10192):29-38. PubMed ID: 31171419
[TBL] [Abstract][Full Text] [Related]
9. Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study.
Garderet L; Beohou E; Caillot D; Stoppa AM; Touzeau C; Chretien ML; Karlin L; Moreau P; Fontan J; Blaise D; Polge E; Gueye MS; Ikhlef S; Marjanovic Z; Labopin M; Mohty M
Haematologica; 2016 Nov; 101(11):1390-1397. PubMed ID: 27612987
[TBL] [Abstract][Full Text] [Related]
10. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
Kyle RA
Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
[TBL] [Abstract][Full Text] [Related]
11. Management of multiple myeloma in the newly diagnosed patient.
Mateos MV; San Miguel JF
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):498-507. PubMed ID: 29222298
[TBL] [Abstract][Full Text] [Related]
12. Clinical treatment of newly diagnosed multiple myeloma.
Cejalvo MJ; de la Rubia J
Expert Rev Hematol; 2015 Oct; 8(5):595-611. PubMed ID: 26327587
[TBL] [Abstract][Full Text] [Related]
13. International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation.
Palumbo A; Sezer O; Kyle R; Miguel JS; Orlowski RZ; Moreau P; Niesvizky R; Morgan G; Comenzo R; Sonneveld P; Kumar S; Hajek R; Giralt S; Bringhen S; Anderson KC; Richardson PG; Cavo M; Davies F; Bladé J; Einsele H; Dimopoulos MA; Spencer A; Dispenzieri A; Reiman T; Shimizu K; Lee JH; Attal M; Boccadoro M; Mateos M; Chen W; Ludwig H; Joshua D; Chim J; Hungria V; Turesson I; Durie BG; Lonial S;
Leukemia; 2009 Oct; 23(10):1716-30. PubMed ID: 19494840
[TBL] [Abstract][Full Text] [Related]
14. Advances in the autologous and allogeneic transplantation strategies for multiple myeloma.
Nishihori T; Alsina M
Cancer Control; 2011 Oct; 18(4):258-67. PubMed ID: 21976244
[TBL] [Abstract][Full Text] [Related]
15. FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma.
Pulte ED; Dmytrijuk A; Nie L; Goldberg KB; McKee AE; Farrell AT; Pazdur R
Oncologist; 2018 Jun; 23(6):734-739. PubMed ID: 29438096
[TBL] [Abstract][Full Text] [Related]
16. Phase 3 trial of three thalidomide-containing regimens in patients with newly diagnosed multiple myeloma not transplant-eligible.
Hungria VT; Crusoé EQ; Maiolino A; Bittencourt R; Fantl D; Maciel JF; Pessoa de Magalhaes RJ; Almeida MS; Cury P; Hisgashi F; Peres AL; Chiattone CS
Ann Hematol; 2016 Jan; 95(2):271-8. PubMed ID: 26518211
[TBL] [Abstract][Full Text] [Related]
17. Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?
Klepin HD; Hurd DD
Bone Marrow Transplant; 2006 Nov; 38(9):585-92. PubMed ID: 16953209
[TBL] [Abstract][Full Text] [Related]
18. [Multiple Myeloma - Current Status in Diagnostic Testing and Therapy].
Kehrer M; Koob S; Strauss A; Wirtz DC; Schmolders J
Z Orthop Unfall; 2017 Oct; 155(5):575-586. PubMed ID: 28806822
[No Abstract] [Full Text] [Related]
19. The Role of Salvage Second Autologous Hematopoietic Cell Transplantation in Relapsed Multiple Myeloma.
Hagen PA; Stiff P
Biol Blood Marrow Transplant; 2019 Mar; 25(3):e98-e107. PubMed ID: 30537552
[TBL] [Abstract][Full Text] [Related]
20. Impact of bone marrow plasma cells percentage on survival at diagnosis and pre-transplant period in newly diagnosed multiple myeloma: Experience of a single center from Turkey.
Ciftciler R; Goker H; Buyukasık Y; Aladag E; Saglam EA; Demiroglu H
Transfus Apher Sci; 2019 Jun; 58(3):313-317. PubMed ID: 30928228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]